Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure

PHASE3CompletedINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Glaucoma, Primary Open Angle (POAG)Ocular Hypertension
Interventions
PROCEDURE

GSS questionnaire

D0, D30 and D84

PROCEDURE

IOP

D0, D30 and D84

DRUG

LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION

in the evening during 84 days

PROCEDURE

Visual acuity

D0 and D84

Trial Locations (102)

10000

Pfizer Investigational Site, Troyes

13004

Pfizer Investigational Site, Marseille

13005

Pfizer Investigational Site, Marseille

13008

Pfizer Investigational Site, Marseille

13009

Pfizer Investigational Site, Marseille

13300

Pfizer Investigational Site, Salon-de-Provence

14000

Pfizer Investigational Site, Caen

15000

Pfizer Investigational Site, Aurillac

17100

Pfizer Investigational Site, Saintes

21800

Pfizer Investigational Site, Quetigny

22300

Pfizer Investigational Site, Lannion

25000

Pfizer Investigational Site, Besançon

25200

Pfizer Investigational Site, Montbéliard

28000

Pfizer Investigational Site, Chartres

28200

Pfizer Investigational Site, Châteaudun

30600

Pfizer Investigational Site, Vauvert

31000

Pfizer Investigational Site, Toulouse

33000

Pfizer Investigational Site, Bordeaux

33210

Pfizer Investigational Site, Langon

34500

Pfizer Investigational Site, Béziers

37110

Pfizer Investigational Site, Château-Renault

37400

Pfizer Investigational Site, Amboise

37800

Pfizer Investigational Site, Sainte-Maure-de-Touraine

40100

Pfizer Investigational Site, Dax

41100

Pfizer Investigational Site, Vendôme

42300

Pfizer Investigational Site, Roanne

44000

Pfizer Investigational Site, Nantes

45200

Pfizer Investigational Site, Montargis

46100

Pfizer Investigational Site, Figeac

47000

Pfizer Investigational Site, Agen

51000

Pfizer Investigational Site, Châlons-en-Champagne

54800

Pfizer Investigational Site, Jarny

59037

Pfizer Investigational Site, Lille

59530

Pfizer Investigational Site, Le Quesnoy

62290

Pfizer Investigational Site, Nœux-les-Mines

63000

Pfizer Investigational Site, Clermont-Ferrand

63100

Pfizer Investigational Site, Clermont-Ferrand

63170

Pfizer Investigational Site, Aubière

63400

Pfizer Investigational Site, Chamalieres-Royat

64000

Pfizer Investigational Site, Pau

66000

Pfizer Investigational Site, Perpignan

67310

Pfizer Investigational Site, Wasselonne

67500

Pfizer Investigational Site, Haguenau

68000

Pfizer Investigational Site, Colmar

68100

Pfizer Investigational Site, Mulhouse

69001

Pfizer Investigational Site, Lyon

69006

Pfizer Investigational Site, Lyon

69009

Pfizer Investigational Site, Lyon

69140

Pfizer Investigational Site, Rillieux-la-Pape

69330

Pfizer Investigational Site, Meyzieu

70300

Pfizer Investigational Site, Luxeuil-les-Bains

71100

Pfizer Investigational Site, Chalon-sur-Saône

72000

Pfizer Investigational Site, Le Mans

72200

Pfizer Investigational Site, La Flèche

73000

Pfizer Investigational Site, Chambéry

75007

Pfizer Investigational Site, Paris

75008

Pfizer Investigational Site, Paris

75013

Pfizer Investigational Site, Paris

75018

Pfizer Investigational Site, Paris

77100

Pfizer Investigational Site, Meaux

77120

Pfizer Investigational Site, Coulommiers

77140

Pfizer Investigational Site, Nemours

77270

Pfizer Investigational Site, Villeparisis

78000

Pfizer Investigational Site, Versailles

78180

Pfizer Investigational Site, Montigny-le-Bretonneux

78300

Pfizer Investigational Site, Poissy

78340

Pfizer Investigational Site, Les Clayes-sous-Bois

78570

Pfizer Investigational Site, Andrésy

80000

Pfizer Investigational Site, Amiens

80700

Pfizer Investigational Site, Roye

82100

Pfizer Investigational Site, Castelsarrasin

83000

Pfizer Investigational Site, Toulon

83400

Pfizer Investigational Site, Hyères

83600

Pfizer Investigational Site, Fréjus

87100

Pfizer Investigational Site, Limoges

90000

Pfizer Investigational Site, Belfort

91150

Pfizer Investigational Site, Étampes

91400

Pfizer Investigational Site, Orsay

92130

Pfizer Investigational Site, Issy-les-Moulineaux

92140

Pfizer Investigational Site, Clamart

92330

Pfizer Investigational Site, Sceaux

92390

Pfizer Investigational Site, Villeneuve-la-Garenne

92600

Pfizer Investigational Site, Asnières-sur-Seine

93260

Pfizer Investigational Site, Les Lilas

93290

Pfizer Investigational Site, Tremblay-en-France

93500

Pfizer Investigational Site, Pantin

94100

Pfizer Investigational Site, Saint-Maur-des-Fossés

94200

Pfizer Investigational Site, Ivry-sur-Seine

95190

Pfizer Investigational Site, Goussainville

95270

Pfizer Investigational Site, Viarmes

95400

Pfizer Investigational Site, Villiers-le-Bel

921090

Pfizer Investigational Site, Meudon

01000

Pfizer Investigational Site, Bourg-en-Bresse

06400

Pfizer Investigational Site, Cannes

Unknown

Pfizer Investigational Site, Chassieu

03000

Pfizer Investigational Site, Moulins

06000

Pfizer Investigational Site, Nice

08025

Pfizer Investigational Site, Orléans

06190

Pfizer Investigational Site, Roquebrune-Cap-Martin

09200

Pfizer Investigational Site, Saint-Girons

06700

Pfizer Investigational Site, Saint-Laurent-du-Var

02100

Pfizer Investigational Site, Saint-Quentin

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00230763 - Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure | Biotech Hunter | Biotech Hunter